Skip to main content
. 2018 Feb 21;48(4):303–307. doi: 10.1093/jjco/hyy013

Figure 2.

Figure 2.

Survival curves of surgically treated lung adenocarcinoma patients. (A) RFS and OS according to GCLC mRNA expression level; (B) according to xCT; (C) according to all CD44; (D) according to CD44v8-10 (A–D: N = 92) and (E) post-recurrence survival compared with GCLC expression level (N = 22).